Document is current
Any future updates will be listed below
-
Authors
Denorme, Frederik
Rustad, John L.
Portier, Irina
Crandell, Jacob L.
de Araujo, Claudia V.
Cody, Mark J.
Campbell, Robert A.
Yost, Christian C.
- License Information
-
More Information
Article History
Received: 3 March 2022
Revised: 25 June 2022
Accepted: 9 July 2022
First Online: 28 July 2022
Competing interests
: C.C.Y. authors a US patent (patent 232,023 B2) held by the University of Utah for the use of NET-inhibitory peptides for the “treatment of and prophylaxis against inflammatory disorders,” for which PEEL Therapeutics, Inc. holds the exclusive license. The other authors declare that no additional conflict of interest exists.
